Abstract
Colorectal cancer (CRC) is the second most deadly and the third most commonly diagnosed cancer in the world. CRC treatment is mainly based on surgery, chemotherapy, and even though the probability of complications after surgery is very low, chemo drugs affect the patient’s quality of life. Multiple studies have shown a strong correlation between diet and the onset and progression of CRC. Thus, the consumption of dietary nutraceuticals for its treatment and prevention has been suggested as a promising option. Peptides have increasingly become of interest in human health due to their antioxidant, antihypertensive, and anticancer potential. In recent years, there have been extensive reports on peptides with anti-tumor activity, and some studies suggest that peptides modulate cell proliferation, evasion of cell death, and metastasis in malignant cells. Plant-derived peptides such as soybean, bean, and rice have received main attention. In this review, we show evidence of several mechanisms through which bioactive peptides exert anti-tumor activity over in vitro and in vivo CRC models. We also report the current status of major production techniques, as well as limitations and future perspectives.
Similar content being viewed by others
Abbreviations
- BBTIs:
-
Bowman-Birk trypsin inhibitors
- CDKs:
-
Cyclin-dependent kinases
- CDK2:
-
Cyclin-dependent kinase 2
- CRC:
-
Colorectal cancer
- GI:
-
Gastrointestinal
References
Ferlay J, Ervik M, Lam F, Cfolombet M, Mery L, Piñeros M, Znaor A, Soejomataram I, Bray F (2018) Cancer today. Global Cancer Observatory. https://gco.iarc.fr/today. Accessed 11 August 2020
Redondo-Blanco S, Fernández J, Gutiérrez-del-Río I, Villar CJ, Lombó F (2017) New insights toward colorectal cancer chemotherapy using natural bioactive compounds. Front Pharmacol 8:109. https://doi.org/10.3389/fphar.2017.00109
Aune D, Chan DS, Lau R, Vieira R, Greenwood DC, Kampman E, Norat T (2011) Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. Br Med J 343:d6617. https://doi.org/10.1136/bmj.d6617
Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, Kampman E, Norat T (2011) Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One 6:e20456. https://doi.org/10.1371/journal.pone.0020456
Fan Y, Jin X, Man C, Gao Z, Wang X (2017) Meta-analysis of the association between the inflammatory potential of diet and colorectal cancer risk. Oncotarget 8:59592. https://doi.org/10.18632/oncotarget.19233
Pan P, Jianhua Y, Wang LS (2018) Colon cancer: what we eat. Sur Oncol Clin N Am 27:243–267. https://doi.org/10.1016/j.soc.2017.11.002
González-Montoya M, Hernández-Ledesma B, Silván JM, Mora-Escobedo R, Martínez-Villaluenga C (2018) Peptides derived from in vitro gastrointestinal digestion of germinated soybean proteins inhibit human colon cancer cells proliferation and inflammation. Food Chem 242:75–82. https://doi.org/10.1016/j.foodchem.2017.09.035
Ortiz-Martinez M, Winkler R, García-Lara S (2014) Preventive and therapeutic potential of peptides from cereals against cancer. J Proteome 5:165–183. https://doi.org/10.1016/j.jprot.2014.03.044
Henchion M, Hayes M, Mullen A, Fenelon M, Tiwari B (2017) Future protein supply and demand: strategies and factors influencing a sustainable equilibrium. Foods 6:53. https://doi.org/10.3390/foods6070053
Rizzello CG, Tagliazucchi D, Babini E, Rutella GS, Taneyo DL, Gianotti A (2016) Bioactive peptides from vegetable food matrices: research trends and novel biotechnologies for synthesis and recovery. J Funct Foods 27:549–569. https://doi.org/10.1016/j.jff.2016.09.023
Marqus S, Pirogova E, Piva TJ (2017) Evaluation of the use of therapeutic peptides for cancer treatment. J Biomed Sci 24:21. https://doi.org/10.1186/s12929-017-0328-x
Seeberger PH, Els-Heindl S, Beck-Sickinger AG (2014) Automated solid-phase peptide synthesis to obtain therapeutic peptides. Beilstein J Org Chem 10:1197–1212. https://doi.org/10.3762/bjoc.10.118
Trier N, Hansen P, Houen G (2019) Peptides, antibodies, peptide antibodies and more. Int J Mol Sci 20:6289. https://doi.org/10.3390/ijms20246289
Chakrabarti S, Guha S, Majumder K (2018) Food-derived bioactive peptides in human health: challenges and opportunities. Nutrients 10:1738. https://doi.org/10.3390/nu10111738
Zhang M, Mu TH (2018) Contribution of different molecular weight fractions to anticancer effect of sweet potato protein hydrolysates by six proteases on HT-29 colon cancer cells. Int J Food Sci Tech 53:25–532. https://doi.org/10.1111/ijfs.13625
Ma S, Huang D, Zhai M, Yang L, Peng S, Chen C (2015) Isolation of a novel bio-peptide from walnut residual protein inducing apoptosis and autophagy on cancer cells. BMC Complem Alter M 15:413. https://doi.org/10.1186/s12906-015-0940-9
Jahanbani R, Ghaffari SM, Salami M, Vahdati K, Sepehri H, Sarvestani NN (2016) Antioxidant and anticancer activities of walnut (Juglans regia L.) protein hydrolysates using different proteases. Plant Foods Hum Nutr 71:402–409. https://doi.org/10.1007/s11130-016-0576-z
Chui H, Chan M, Hernandez D, Chong P, McCorrister S, Robinson A (2015) Rapid, sensitive, and specific Escherichia coli H antigen typing by matrix-assisted laser desorption ionization–time of flight-based peptide mass fingerprinting. J Clin Microbiol 53:2480–2485. https://doi.org/10.1128/JCM.00593-15
Yamagishi H, Kuroda H, Imai Y, Hiraishi H (2016) Molecular pathogenesis of sporadic colorectal cancers. Chin J Cancer 35:4. https://doi.org/10.1186/s40880-015-0066-y
Jass J (2007) Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50:113–130. https://doi.org/10.1111/j.1365-2559.2006.02549.x
Markowitz SD, Bertagnolli MM (2009) Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 361:2449–2460. https://doi.org/10.1056/NEJMra0804588
Yu IS, Cheung WK (2018) Metastatic colorectal cancer in the era of personalized medicine: a more tailored approach to systemic therapy. Can J Gastroenterol Hepatol 2018:9450754–9450711. https://doi.org/10.1155/2018/9450754
Long AG, Lundsmith ET, Hamilton KE (2017) Inflammation and colorectal cancer. Curr Colorectal Cancer Rep 13:341–351. https://doi.org/10.1007/s11888-017-0373-6
Chiangjong W, Chutipongtanate S, Hongeng S (2020) Anticancer peptides: physicochemical property, functional aspect and trend in clinical application (review). Int J Oncol 57:678–696. https://doi.org/10.3892/ijo.2020.5099
Korhonen H, Pihlanto A (2006) Bioactive peptides: production and functionality. Int Dairy J 16:945–960. https://doi.org/10.1016/j.idairyj.2005.10.012
Luna-Vital DA, de Mejía EG, Loarca-Piña G (2016) Selective mechanism of action of dietary peptides from common bean on HCT116 human colorectal cancer cells through loss of mitochondrial membrane potential and DNA damage. J Funct Foods 23:24–39. https://doi.org/10.1016/j.jff.2016.02.021
Vermeirssen V, Camp JV, Verstraete W (2004) Bioavailability of angiotensin I converting enzyme inhibitory peptides. Br J Nutr 92:357–366. https://doi.org/10.1079/bjn20041189
Renukuntla J, Vadlapudi AD, Patel A, Boddu SHS, Mitra AK (2013) Approaches for enhancing oral bioavailability of peptides and proteins. Int J Pharm 447:75–93. https://doi.org/10.1016/j.ijpharm.2013.02.030
Pan X, Xu J, Jia X (2020) Research progress evaluating the function and mechanism of anti-tumor peptides. Cancer Manag Res 12:397–409. https://doi.org/10.2147/CMAR.S232708
Gupta S, Kapoor P, Chaudhary K, Gautam A, Kumar R, Raghava GPS (2013) In silico approach for predicting toxicity of peptides and proteins. PLoS One 8:e73957. https://doi.org/10.1371/journal.pone.0073957
Rayaprolu SJ, Hettiarachchy NS, Chen P, Kannan A, Mauromostakos A (2013) Peptides derived from high oleic acid soybean meals inhibit colon, liver and lung cancer cell growth. Food Res Int 50:282–288. https://doi.org/10.1016/j.foodres.2012.10.021
Rayaprolu SJ, Hettiarachchy NS, Horax R, Kumar-Phillips G (2017) Purification and characterization of a peptide from soybean with cancer cell proliferation inhibition. J Food Biochem 41:e12374. https://doi.org/10.1111/jfbc.12374
Kannan A, Hettiarachchy N, Johnson MG, Nannapaneni R (2008) Human colon and liver cancer cell proliferation inhibition by peptide hydrolysates derived from heat-stabilized defatted rice bran. J Agr Food Chem 56:11643–11647. https://doi.org/10.1021/jf802558v
Kannan A, Hettiarachchy NS, Lay JO, Liyanage R (2010) Human cancer cell proliferation inhibition by a pentapeptide isolated and characterized from rice bran. Peptides 31:1629–1634. https://doi.org/10.1016/j.peptides.2010.05.018
Kannan A, Hettiarachchy N, Narayan S (2009) Colon and breast anticancer effects of peptide hydrolysates derived from rice bran. TOBCJ 2:17–20. https://doi.org/10.2174/1874847300902010017
Savitskaya M, Onishchenko G (2015) Mechanisms of apoptosis. Biochem Mosc 80:1393–1405. https://doi.org/10.1134/S0006297915110012
Li Z, Zhao C, Li Z, Zhao Y, Shan S, Shi T (2014) Reconstructed mung bean trypsin inhibitor targeting cell surface GRP78 induces apoptosis and inhibits tumor growth in colorectal cancer. Int J Biochem Cell Bioll 47:68–75. https://doi.org/10.1016/j.biocel.2013.11.022
Pistritto G, Trisciuoglio D, Ceci C, Garufi A, D’Orazi G (2016) Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY) 8:603-619. https://doi.org/10.18632/aging.100934
Budchart P, Khamwut A, Sinthuvanich C, Ratanapo S, Poovorawan Y, T-Thienprasert NP (2017) Partially purified Gloriosa superba peptides inhibit colon cancer cell viability by inducing apoptosis through p53 upregulation. Am J Med Sci 354:423–429. https://doi.org/10.1016/j.amjms.2017.06.005
Luna-Vital DA, de Mejía EG, Dia VP, Loarca-Piña G (2014) Peptides in common bean fractions inhibit human colorectal cancer cells. Food Chem 157:347–355. https://doi.org/10.1016/j.foodchem.2014.02.050
Gao C, Sun R, Xie YR, Jiang AL, Lin M, Li M (2017) The soy-derived peptide Vglycin inhibits the growth of colon cancer cells in vitro and in vivo. Exp Biol Med 242:1034–1043. https://doi.org/10.1177/1535370217697383
Lule VK, Garg S, Pophaly SD, Tomar SK (2015) Potential health benefits of lunasin: a multifaceted soy-derived bioactive peptide. J Food Sci 80:485–494. https://doi.org/10.1111/1750-3841.12786
Fernández-Tomé S, Xu F, Han Y, Hernández-Ledesma B, Xiao H (2020) Inhibitory effects of peptide lunasin in colorectal cancer HCT-116 cells and their tumorsphere-derived subpopulation. Int J Mol Sci 21:537. https://doi.org/10.3390/ijms21020537
Sabbione AC, Ogutu FO, Scilingo A, Zhang M, Añón MC, Mu TH (2019) Antiproliferative effect of amaranth proteins and peptides on HT-29 human colon tumor cell line. Plants Foods Hum Nutr 74:107–114. https://doi.org/10.1007/s11130-018-0708-8
Allaoui A, Gascón S, Benomar S, Quero J, Osada J, Nasri M (2019) Protein hydrolysates from fenugreek (Trigonella foenum graecum) as nutraceutical molecules in colon cancer treatment. Nutrients 11:724. https://doi.org/10.3390/nu11040724
Reilly NM, Novara L, Nicolantonio FD, Bardelli A (2019) Exploiting DNA repair defects in colorectal cancer. Mol Oncol 13:681–700. https://doi.org/10.1002/1878-0261.12467
Tonnus W, Linkermann A (2017) The in vivo evidence for regulated necrosis. Immunol Rev 277:128–149. https://doi.org/10.1111/imr.12551
Cho YS, Park SY (2014) Harnessing of programmed necrosis for fighting against cancers. Biomol Ther 22:167–175. https://doi.org/10.4062/biomolther.2014.046
Bagnjuk K, Stöckl JB, Fröhlich T, Arnold GJ, Behr R, Berg U (2019) Necroptosis in primate luteolysis: a role for ceramide. Cell Death Discov 5:1–14. https://doi.org/10.1038/s41420-019-0149-7
Otto T, Sicinski P (2017) Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer 17:93–115. https://doi.org/10.1038/nrc.2016.138
Qasim BJ, Ali HH, Hussein AG (2012) Immunohistochemical expression of PCNA and CD34 in colorectal adenomas and carcinomas using specified automated cellular image analysis system: a clinicopathologic study. Saudi J Gastroenterol 18:268–276. https://doi.org/10.4103/1319-3767.98435
Ogino S, Goeyl A (2008) Molecular classification and correlates in colorectal cancer. J Mol Diagn 10:13–27. https://doi.org/10.2353/jmoldx.2008.070082
Qie S, Diehl JA (2020) Cyclin D degradation by E3 ligases in cancer progression and treatment. Semin Cancer Biol 30:s1044. https://doi.org/10.1016/j.semcancer.2020.01.012
Chen YT, Tsao SC, Tsai HP, Wang JY, Chai CY (2016) Serine protease inhibitor Kazal type 1 (SPINK1) as a prognostic marker in stage IV colon cancer patients receiving cetuximab based targeted therapy. J Clin Pathol 69:974–978. https://doi.org/10.1136/jclinpath-2016-203638
Clemente A, Marín-Manzano MC, Jiménez E, Arques MC, Domoney C (2012) The antiproliferative effect of TI1B, a major Bowman–Birk isoinhibitor from pea (Pisum sativum L.), on HT29 colon cancer cells is mediated through protease inhibition. Br J Nutr 108:135–144. https://doi.org/10.1017/S000711451200075X
Caccialupi P, Ceci LR, Siciliano RA, Pignone D, Clemente A, Sonnante G (2010) Bowman-Birk inhibitors in lentil: heterologous expression, functional characterization and antiproliferative properties in human colon cancer cells. Food Chem 120:1058–1066. https://doi.org/10.1016/j.foodchem.2009.11.051
Ragg EM, Galbusera V, Scarafoni A, Negri A, Tedeschi G, Consonni A (2006) Inhibitory properties and solution structure of a potent Bowman–Birk protease inhibitor from lentil (Lens culinaris L) seeds. FEBS J 273:402–439. https://doi.org/10.1111/j.1742-4658.2006.05406.x
Reyes Díaz A, Del-Toro-Sánchez CL, Rodríguez-Figueroa J, Valdéz-Hurtado S, Wong-Corral FJ, Borboa-Flores J, Gonzáez-Osuna MF, Perez-Perez LM, González-Vega RI (2019) Legumes proteins as promising source of anti-inflammatory peptides. Curr Protein Pept Sci 20:1204–1217. https://doi.org/10.2174/1389203720666190430110647
Chan-Zapata I, Arana-Argáez VE, Torres-Romero JC, Segura-Campos MR (2019) Anti-inflammatory effects of the protein hydrolysate and peptide fraction isolated from Salvia hispanica L. seeds. F Agr Immunol 30:786–803. https://doi.org/10.1080/09540105.2019.1632804
Yalcin S, Basman A (2015) Effects of infrared treatment on urease, trypsin inhibitor and lipoxygenase activities of soybean samples. Food Chem 15:169–203. https://doi.org/10.1016/j.foodchem.2014.07.114
Cruz-Huerta E, Fernández-Tomé S, Arques MC, Amigo L, Recio I, Clemente A (2015) The protective role of the Bowman-Birk protease inhibitor in soybean lunasin digestion: the effect of released peptides on colon cancer growth. Food Funct 6:2626–2635. https://doi.org/10.1039/C5FO00454C
De Angelis E, Pilolli R, Bavaro SL, Monaci L (2017) Insight into the gastro-duodenal digestion resistance of soybean proteins and potential implications for residual immunogenicity. Food Funct 8:1599–1610. https://doi.org/10.1039/C6FO01788F
Yan J, Zhao J, Yang R, Zhao W (2019) Bioactive peptide with antidiabetic properties: a review. Food Sci Technol 54:1909–1919. https://doi.org/10.1111/ijfs.14090
Lorensen E, Prevosto R, Wilson KA (1981) The appearance of new active forms of trypsin inhibitor in germinating mung bean (Vigna radiata) seeds. Plant Physiol 68:88–92. https://doi.org/10.1104/pp.68.1.88
Sánchez-Chino XM, Jiménez Martínez C, León-Espinosa EB, Garduño-Siciliano L, Álvarez-González I, Madrigal-Bujaidar E (2019) Protective effect of chickpea protein hydrolysates on colon carcinogenesis associated with a hypercaloric diet. J Am Coll Nutr 38:162–170. https://doi.org/10.1080/07315724.2018.1487809
Świeca M, Baraniak B (2013) Influence of elicitation with H2O2 on phenolics content, antioxidant potential and nutritional quality of Lens culinaris sprouts. J Sci Food Agric 94:489–496. https://doi.org/10.1002/jsfa.6274
Giovannini C, Maiuri L, De Vincenzi M (1995) Cytotoxic effect of prolamin-derived peptides on in vitro cultures of cell line Caco-2: implications for coeliac disease. Toxicol in Vitro 9:251–255. https://doi.org/10.1016/0887-2333(94)00212-D
Jain A, Jain SK (2016) Optimization of chitosan nanoparticles for colon tumors using experimental design methodology. Artif Cells Nanomed Biotechnol 44:1917–1926. https://doi.org/10.3109/21691401.2015.1111236
El-Maghawry E, Tadros MI, Elkheshen SA, Abd-Elbary A (2020) Eudragit®-S100 coated PLGA nanoparticles for colon targeting of Etoricoxib: optimization and pharmacokinetic assessments in healthy human volunteers. Int J Nanomedicine 15:3965–3980. https://doi.org/10.2147/IJN.S244124
Funding
Thanks to CONACYT for providing a scholarship to Aviles-Gaxiola (597872).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Avilés-Gaxiola, S., Gutiérrez-Grijalva, E.P., León-Felix, J. et al. Peptides in Colorectal Cancer: Current State of Knowledge. Plant Foods Hum Nutr 75, 467–476 (2020). https://doi.org/10.1007/s11130-020-00856-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11130-020-00856-6